Literature DB >> 2989913

Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation.

C H Campbell, T L Barber, R C Knudsen, L M Swaney.   

Abstract

Gamma irradiation is being tested as a means of inactivating bluetongue virus (BTV) for use in vaccines. Exposure of BTV 17 to various levels of irradiation revealed that a dose of approximately 0.6 megarad was required to reduce the virus titer by one log10, or 90%. To test the immunogenicity of irradiated BTV, mouse brain passaged virus and concentrated cell culture passaged virus were inactivated by 6 megarads of gamma irradiation, and vaccines were prepared by emulsifying the virus preparations in equal volumes of a modified incomplete Freund's adjuvant. These vaccines stimulated the production of neutralizing antibodies in mice and sheep, a cell mediated immune response in mice, and a protective immune response in sheep. The results suggest that gamma irradiation would be an effective means of inactivating BTV for the preparation of vaccines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989913

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  3 in total

Review 1.  The role of nuclear technologies in the diagnosis and control of livestock diseases--a review.

Authors:  Gerrit J Viljoen; Antony G Luckins
Journal:  Trop Anim Health Prod       Date:  2012-10       Impact factor: 1.559

Review 2.  Advances in Irradiated Livestock Vaccine Research and Production Addressing the Unmet Needs for Farmers and Veterinary Services in FAO/IAEA Member States.

Authors:  Hermann Unger; Richard T Kangethe; Fatima Liaqat; Gerrit J Viljoen
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 3.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.